Irinotecan and Cisplatin for High Grade Neuroendocrine Carcinoma of the Gastrointestinal Tract

Clinical trial NCT00353015 · COMPLETED

Trial details

NCT number: NCT00353015
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Gastrointestinal Cancer Carcinoma, Neuroendocrine

Start date: 2003-03-01
Primary completion: 2007-12-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.